beta

ALNA

Allena Pharmaceuticals Inc.

Alna

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Allena Pharmaceuticals Inc is a clinical biopharmaceutical company. It focuses on developing and commercializing oral enzyme therapeutics to treat patients with rare and severe metabolic and kidney disorders.

Market Cap: 180 Million

Primary Exchange: Nasdaq Global Select

Website: http://www.allenapharma.com

Shares Outstanding: 20.7 Million

Float: 17.1 Million

Dividend: 0.0 (0.0%)

Beta: 2.713619

Sector: Healthcare

Industry: Biotechnology

Short Interest (Jan 12, 2018): 109 Thousand

Ethical Flags

Animal testing

Longest drawdown: 391 trading days

From: 2018-04-04 To: 2019-10-18

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud